News + Filings Transactions
|
Humer Franz B
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/13/2023 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 74.6k | $0.00 | $0 | | 06/13/2023 |
| 06/15/2022 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 44.2k | $0.00 | $0 | | 06/15/2022 |
| 06/10/2021 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 16.5k | $0.00 | $0 | | 06/10/2021 |
| 06/05/2020 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 10k | $0.00 | $0 | | 06/05/2020 |
| 06/06/2019 | Allogene Therapeutics, Inc. | ALLO | Grant | Common Stock | 16.4k | $0.00 | $0 | | 06/06/2019 |
| 04/01/2019 | CITIGROUP INC | C | Grant | Common Stock | 151.3481 | $63.05 | $9.5k | See Footnote | 04/01/2019 |
| 04/01/2019 | CITIGROUP INC | C | Grant | Common Stock | 14.6923 | $63.05 | $926.3 | | 04/01/2019 |
| 02/14/2019 | CITIGROUP INC | C | Grant | Common Stock | 600.692 | $0.00 | $0 | | 02/14/2019 |
| 01/02/2019 | CITIGROUP INC | C | Grant | Common Stock | 142.8498 | $58.01 | $8.3k | See Footnote | 01/02/2019 |
| 01/02/2019 | CITIGROUP INC | C | Grant | Common Stock | 36.2104 | $58.01 | $2.1k | | 01/02/2019 |
| 10/15/2018 | Allogene Therapeutics, Inc. | ALLO | Conversion | Series A Convertible Preferred Stock | 14.3k | $0.00 | $0 | | 10/15/2018 |
| 10/15/2018 | Allogene Therapeutics, Inc. | ALLO | Conversion | Common Stock | 74.9k | $0.00 | $0 | | 10/15/2018 |
| 10/15/2018 | Allogene Therapeutics, Inc. | ALLO | Purchase | Common Stock | 30k | $18.00 | $540k | | 10/15/2018 |
| 10/01/2018 | CITIGROUP INC | C | Grant | Common Stock | 29.6595 | $70.35 | $2.1k | | 10/01/2018 |
| 10/01/2018 | CITIGROUP INC | C | Grant | Common Stock | 117.0064 | $70.35 | $8.2k | See Footnote | 10/01/2018 |
| 07/01/2018 | CITIGROUP INC | C | Grant | Common Stock | 21.848 | $67.57 | $1.5k | | 07/01/2018 |
| 07/01/2018 | CITIGROUP INC | C | Grant | Common Stock | 86.1906 | $67.57 | $5.8k | See Footnote | 07/01/2018 |
| 04/01/2018 | CITIGROUP INC | C | Grant | Common Stock | 11.1031 | $74.44 | $826.5 | | 04/01/2018 |
| 04/01/2018 | CITIGROUP INC | C | Grant | Common Stock | 77.8794 | $74.44 | $5.8k | See Footnote | 04/01/2018 |
| 02/15/2018 | CITIGROUP INC | C | Grant | Common Stock | 2k | $0.00 | $0 | | 02/15/2018 |
| 01/02/2018 | CITIGROUP INC | C | Grant | Common Stock | 58.8524 | $75.63 | $4.5k | See Footnote | 01/02/2018 |
| 01/02/2018 | CITIGROUP INC | C | Grant | Common Stock | 28.3209 | $75.63 | $2.1k | | 01/02/2018 |
| 04/01/2017 | CITIGROUP INC | C | Grant | Common Stock | 36.0432 | $61.11 | $2.2k | See Footnote | 04/01/2017 |
| 04/01/2017 | CITIGROUP INC | C | Grant | Common Stock | 10.6831 | $61.11 | $652.8 | | 04/01/2017 |
| 02/16/2017 | CITIGROUP INC | C | Grant | Common Stock | 2.5k | $0.00 | $0 | | 02/16/2017 |
| 06/01/2016 | Kite Pharma, Inc. | KITE | Grant | Common Stock | 2k | $0.00 | $0 | | 06/01/2016 |
| 06/01/2016 | Kite Pharma, Inc. | KITE | Grant | Director Stock Option (Right to Buy) | 7k | $50.87 | $356.1k | | 06/01/2016 |
| 04/01/2016 | CITIGROUP INC | C | Grant | Common Stock | 3.5336 | $42.10 | $148.8 | | 04/01/2016 |
| 04/01/2016 | CITIGROUP INC | C | Grant | Common Stock | 12.6735 | $42.10 | $533.5 | See Footnote | 04/01/2016 |
| 03/10/2016 | Kite Pharma, Inc. | KITE | Grant | Common Stock | 2.1k | $0.00 | $0 | | 03/10/2016 |
| 01/01/2013 | CITIGROUP INC | C | Grant | Common Stock | 1.1 | $36.62 | $40.3 | | 01/01/2013 |
| 10/01/2012 | CITIGROUP INC | C | Grant | Common Stock | 1.2 | $32.35 | $38.8 | | 10/01/2012 |
|